Evidence map›Paper›PMID 35147259›Full record

ArticlePathology international2022

Pathogenesis of follicular thymic hyperplasia associated with rheumatoid arthritis.

Rintaro Ohe, Suran Yang, Daisuke Yamashita, Chihiro Ichikawa, Akihisa Saito, Takanobu Kabasawa, Aya Utsunomiya, Naing Ye Aung, Yuka Urano, Takumi Kitaoka and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Pathology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Rintaro OheDepartment of Pathology, Faculty of Medicine, Yamagata University, Yamagata, Japan.ORCID http://orcid.org/0000-0002-8035-791X
Suran YangDepartment of Pathology, Faculty of Medicine, Yamagata University, Yamagata, Japan.
Daisuke YamashitaDepartment of Pathology, Kobe City Medical Center General Hospital, Kobe, Japan.ORCID http://orcid.org/0000-0002-6167-1794
Chihiro IchikawaDepartment of Diagnostic Pathology, Osaka Women's and Children's Hospital, Osaka, Japan.
Akihisa SaitoDepartment of Diagnostic Pathology, National Hospital Organization Kure Medical Center/Chugoku Cancer Center, Hiroshima, Japan.
Takanobu KabasawaDepartment of Pathology, Faculty of Medicine, Yamagata University, Yamagata, Japan.ORCID http://orcid.org/0000-0001-7349-3748
Aya UtsunomiyaDepartment of Pathology, Faculty of Medicine, Yamagata University, Yamagata, Japan.ORCID http://orcid.org/0000-0003-4646-3273
Naing Ye AungDepartment of Pathology, Faculty of Medicine, Yamagata University, Yamagata, Japan.ORCID http://orcid.org/0000-0001-5309-781X
Yuka UranoDepartment of Pathology, Faculty of Medicine, Yamagata University, Yamagata, Japan.ORCID http://orcid.org/0000-0002-4290-1152
Takumi KitaokaDepartment of Pathology, Faculty of Medicine, Yamagata University, Yamagata, Japan.ORCID http://orcid.org/0000-0002-0989-3082
Kazushi SuzukiDepartment of Pathology, Faculty of Medicine, Yamagata University, Yamagata, Japan.
Daiichiro TakaharaDepartment of Pathology, Faculty of Medicine, Yamagata University, Yamagata, Japan.ORCID http://orcid.org/0000-0002-2698-1834
Akiko SasakiDepartment of Orthopedic Surgery, Faculty of Medicine, Yamagata University, Yamagata, Japan.
Yuya TakakuboDepartment of Orthopedic Surgery, Faculty of Medicine, Yamagata University, Yamagata, Japan.
Michiaki TakagiDepartment of Orthopedic Surgery, Faculty of Medicine, Yamagata University, Yamagata, Japan.
Mitsunori YamakawaDepartment of Pathology, Faculty of Medicine, Yamagata University, Yamagata, Japan.
Mitsuru FutakuchiDepartment of Pathology, Faculty of Medicine, Yamagata University, Yamagata, Japan.ORCID http://orcid.org/0000-0001-8647-583X
Yamagata University · JPKobe City Medical Center General Hospital · JPNational Hospital Organization · JPOsaka Women's and Children's Hospital · JP

Funding

Japan Society for the Promotion of Science JP19K16577Japan Society for the Promotion of Science JP21K06901
6 · The paper itself

Abstract

Lymphoproliferative disorders may occur in patients with rheumatoid arthritis (RA) who are treated with methotrexate. However, follicular thymic hyperplasia (FTH) associated with RA (FTH-RA) is generally not considered a lymphoproliferative disorder. To investigate the pathogenesis of FTH-RA, we examined 12 cases of FTH involving thymic enlargement, four of FTH involving RA and eight of FTH involving myasthenia gravis (MG). Increased numbers and larger germinal center (GC) size were observed in FTH-RA group. The percentage of distorted GCs was 13.3% in FTH-RA group and 3.25% in FTH associated with MG (FTH-MG) group. A greater meshwork of follicular dendritic cells was observed in the GCs of FTH-RA group. Positive indices of CD27

Indexed as

Arthritis, RheumatoidLymphatic DiseasesThymus HyperplasiaDendritic Cells, FollicularHumansMethotrexateMethotrexatefollicular helper T-cellfollicular thymic hyperplasiagerminal centerhumoral immunitymemory B-cellmyasthenia gravismyoid cellrheumatoid arthritis

Identifiers

PMID35147259
PMCPMC9304286
OpenAlexW4211196444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.